Patent · US Expired

Method for the enhancement of lymphocyte activity against tumors

US6054489A · kind A · utility

16Cited by

1References

10Claims

0Family size

Assignee

Loyola University of Chicago · US

Inventors

Stanley Lorens · Forest Park, US
Herbert L. Mathews · Elmhurst, US
John J. Clancy · Naperville, US
Joanna Goral · Woodridge, US
Brigitte Riveline · Paris, FR

Key dates

Filing date	Nov 17, 1997
Grant date	Apr 25, 2000
Priority date	—
Expiry date	Nov 17, 2017

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/2013
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the treatment of an immunocompromised human, e.g., an AIDS or HIV positive patient, for the enhancement of lymphocyte activity against opportunistic microbial pathogens or the treatment of any human for the enhancement of lymphocyte activity against tumors using a lymphocyte-activity-enhancing amount of dextrofenfluramine or a pharmaceutically-acceptable acid addition salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.